Use of the Quinolones in the Prophylaxis and Treatment of Granulocytopenic Immunocompromised Cancer Patients
- 1 January 1993
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 45 (3) , 81-90
- https://doi.org/10.2165/00003495-199300453-00015
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Streptococcal and Enterococcal Bacteremia in Patients with CancerClinical Infectious Diseases, 1992
- Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group.1991
- Pefloxacin and vancomycin vs. gentamicin, colistin sulphate and vancomycin for prevention of infections in granulocytopenic patients: a randomised double-blind studyEuropean Journal of Cancer and Clinical Oncology, 1991
- From the Immunocompromised Host Society: The Design, Analysis, and Reporting of Clinical Trials on the Empirical Antibiotic Management of the Neutropenic Patient: Report of a Consensus PanelThe Journal of Infectious Diseases, 1990
- [Prevention of bacterial infections using ciprofloxacin in granulocytopenic patients with cancer].1989
- Intravenous ciprofloxacin as empirical treatment of febrile neutropenic patientsThe American Journal of Medicine, 1989
- Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemiaThe American Journal of Medicine, 1988
- Gram-positive infections in granulocytopenic patients: an important issue?Journal of Antimicrobial Chemotherapy, 1988
- Oral Norfloxacin for Prevention of Gram-Negative Bacterial Infections in Patients with Acute Leukemia and GranulocytopeniaAnnals of Internal Medicine, 1987
- Trimethoprim-Sulfamethoxazole in the Prevention of Infection in Neutropenic PatientsThe Journal of Infectious Diseases, 1984